Background: Chemerin is a novel chemoattractant adipokine expressed in cardiovascular
system, and its receptor has been detected in the epicardial adipose tissue. Aims: To …

Since chemerin is an adipocytokine whose concentration in blood increases in the subjects
with various cardiac diseases, chemerin may be involved in pathogenesis of cardiac …

Chemerin is a novel adipokine that affects inflammation, insulin resistance, metabolic
syndrome, and cardiovascular diseases. Nonetheless, it is unclear whether chemerin is …

Aims: Chemerin is a novel adipokine that is closely associated with cardiovascular diseases
and glucose homeostasis. This study aimed to investigate the effects of chemerin on insulin …

Background: The adipokine chemerin has been associated with cardiovascular disease. We
investigated the effects of chemerin on viability and intracellular signalling in murine …

Background: Left ventricular hypertrophy (LVH) is an important predictor of cardiovascular
risk and its detection contributes to risk stratification. Chemerin is a secreted protein with a …

Objectives To evaluate chemerin levels in patients with coronary artery disease and detect
the correlation between these levels (if any) with the severity of coronary artery disease …

Background: Chemerin is a newly discovered adipokine, which has been reported to be
associated with the presence of dilated cardiomyopathy (DCM). The present study aims to …

Background Growing evidence suggests that epicardial adipose tissue (EAT) may play a key
role in the pathogenesis and development of coronary artery disease (CAD) by producing …

Objective Chemerin, a newly discovered adipokine, is correlated with hypertension,
diabetes and coronary heart disease. The aim of this study is to investigate the association …